JNJ – johnson & johnson (US:NASDAQ)
Stock Stats
News
Health Canada issues NOC to J&J's CARVYKTI for multiple myeloma [Yahoo! Finance]
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program's Goals [Forbes]
Antihistamine Drugs Industry Report 2025-2030: A $381 Million Opportunity - Johnson & Johnson, Sanofi, Pfizer, and Bayer Experiencing Notable Growth Driven by Substantial R&D Investments [Yahoo! Finance]
Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor [Yahoo! Finance]
Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor
Form 13F-HR JOHNSON & JOHNSON For: Sep 30
Form 25-NSE JOHNSON & JOHNSON Filed by: NEW YORK STOCK EXCHANGE LLC
Form 4/A JOHNSON & JOHNSON For: May 01 Filed by: REED JOHN C
Form 10-Q JOHNSON & JOHNSON For: Sep 29
Form 4 JOHNSON & JOHNSON For: May 22 Filed by: Wolk Joseph J
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.